Moreover, there is growing interest for specific IgE in response prediction also in other settings, such as in atopic dermatitis patients treated with Dupilumab, where Malassezia specific-IgE seems to be associated with the development of Dupilumab-induced facial redness dermatitis (60). The gene discussed is IGHE; the disease is atopic eczema.